Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Saved in:
| Title: | Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. |
|---|---|
| Authors: | Pinter, M.1 (AUTHOR), Sieghart, W.1 (AUTHOR), Hucke, F.1 (AUTHOR), Graziadei, I.2 (AUTHOR), Vogel, W.2 (AUTHOR), Maieron, A.3 (AUTHOR), Königsberg, R.4 (AUTHOR), Weissmann, A.5 (AUTHOR), Kornek, G.6 (AUTHOR), Matejka, J.7 (AUTHOR), Stauber, R.7 (AUTHOR), Buder, R.8 (AUTHOR), Grünberger, B.9 (AUTHOR), Schöniger‐Hekele, M.1 (AUTHOR), Müller, C.1 (AUTHOR), Peck‐Radosavljevic, M.1 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Oct2011, Vol. 34 Issue 8, p949-959. 11p. 5 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
